NCT04463498

Brief Summary

Sleep disorders commonly co-occur with psychiatric disorders. Sleep disorders are often treated with medication or not at all in psychiatric care, although there exist a plethora of documentation of the effectiveness of sleep interventions. There is also an increase in studies showing effectiveness of sleep-interventions when the sleep disorder co-occurs with psychiatric illness. The most common and best documented treatment for insomnia is cognitive behavioral therapy for insomnia (CBTi). There is a great gap in the knowledge on how sleep disorders can be treated effectively in psychiatric care. In this project the investigators therefore seek to investigate the effect of non-pharmacological, group-based treatment in a randomized controlled trial (RCT) where sleep and psychiatric symptoms are the primary outcome measures. CBTi comprise of sleep education, sleep restriction, stimulus control and cognitive restructuring of dysfunctional thoughts about sleep.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
21mo left

Started Dec 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress73%
Dec 2021Dec 2027

First Submitted

Initial submission to the registry

April 6, 2020

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 9, 2020

Completed
1.4 years until next milestone

Study Start

First participant enrolled

December 17, 2021

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

June 18, 2024

Status Verified

June 1, 2024

Enrollment Period

5 years

First QC Date

April 6, 2020

Last Update Submit

June 14, 2024

Conditions

Keywords

sleep disordersinsomniapsychiatric disordersbb-glassesgroup-based cognitive behavioural therapy for insomnia

Outcome Measures

Primary Outcomes (1)

  • Insomnia symptoms

    Measured by the questionnaires Insomnia severity Index (ISI) and Bergen Insomnia Scale (BIS). From sleep diaries; sleep onset latency (SOL), wake after sleep onset (WASO) and sleep efficiency (SE).

    baseline, bi-weekly and post intervention after 8 weeks, follow-up after 12 months

Secondary Outcomes (19)

  • Changes in insomnia diagnosis

    baseline and post intervention after 8 weeks, follow-up after 12 months

  • Changes in insomnia severity

    baseline and post intervention after 8 weeks, follow-up after 12 months

  • Changes in Time in bed (TIB)

    baseline, bi-weekly assesment and post intervention after 8 weeks, follow-up after 12 months

  • Changes in objective early morning awakening (EMA)

    baseline and post intervention after 8 weeks, follow-up after 12 months

  • Changes in objective wake after sleep onset (WASO)

    baseline and post intervention after 8 weeks, follow-up after 12 months

  • +14 more secondary outcomes

Other Outcomes (12)

  • Changes in symptoms of inattention

    baseline and post intervention after 8 weeks, follow-up after 12 months

  • Changes in vigilance

    baseline and post intervention after 8 weeks, follow-up after 12 months

  • Changes in self reported emotion regulation ability

    baseline and post intervention after 8 weeks, follow-up after 12 months

  • +9 more other outcomes

Study Arms (3)

n=15, Sleep-school 8 weeks

EXPERIMENTAL

Patients receive treatment as usual in the psychiatric clinic combined with participation in the sleep school. They have already been given education on sleep regulation and sleep hygiene advice in the first meeting with the sleep-school facilitator.

Behavioral: Group-based cognitive behavioral therapy for insomnia

n=15, Sleep-school 8 weeks and additive bb-glasses

EXPERIMENTAL

Patients receive treatment as usual in the psychiatric clinic combined with participation in the sleep school and additive treatment with bb-glasses. They have already been given education on sleep regulation and sleep hygiene advice in the first meeting with the sleep-school facilitator.

Behavioral: Group-based cognitive behavioral therapy for insomniaBehavioral: Group-based cognitive behavioral therapy for insomnia and additive bb-glasses

n=30 8-week wait list for sleep-school

ACTIVE COMPARATOR

Patients receive treatment as usual in the psychiatric clinic while they wait for participation in the sleep school. They have already been given education on sleep regulation and sleep hygiene advice in the first meeting with the sleep-school facilitator.

Other: 8-week wait list for sleep-school

Interventions

Sleep education, sleep restriction, stimulus control, cognitive restructuring, relaxation techniques

Also known as: Group - CBTi
n=15, Sleep-school 8 weeksn=15, Sleep-school 8 weeks and additive bb-glasses

Treatment as usual in a psychiatric outpatient clinic

Also known as: Treatment as usual
n=30 8-week wait list for sleep-school

Sleep education, sleep restriction, stimulus control, cognitive restructuring, relaxation techniques, bb-glasses worn from 3 hrs before bedtime.

Also known as: Group - CBTi & bb-glasses
n=15, Sleep-school 8 weeks and additive bb-glasses

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients referred to the sleep-school at Bjørgvin DPS psychiatric hospital
  • Patients fulfilling the Diagnostic Manual for Mental Disorders (DSM-V) criteria for insomnia comorbid to moderate to severe psychiatric illness (confirmed F-diagnosis based on the International Statistical Classification of Diseases and Related Health Problems (ICD-11) diagnostic system that are used in Norway in addition to insomnia and/or scores of ≥19 on BDI and/or scores of ≥16 on BAI at the time of referral to the sleep school)

You may not qualify if:

  • Nightwork
  • Patients that do not fulfil the DSM-V criteria for insomnia comorbid to moderate to severe psychiatric illness (confirmed F-diagnosis based on the ICD-10 diagnostic system that are used in Norway in addition to insomnia and/or scores of ≥19 on BDI and/or scores of ≥16 on BAI at the time of referral to the sleep school)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Haukeland University Hospital

Bergen, 5113, Norway

RECRUITING

Related Publications (1)

  • Wilhelmsen-Langeland A, Saxvig IW, Gradisar M, Vagenes VA, Pallesen S, Sorensen L, Fasmer OB, Koenig J, Bjorvatn B, Osnes B. Group cognitive behavioural therapy for insomnia compared with treatment as usual for sleep problems in psychiatric care (the SIP trials): a protocol for a pragmatic, randomised controlled trial. BMJ Open. 2025 Apr 17;15(4):e090997. doi: 10.1136/bmjopen-2024-090997.

MeSH Terms

Conditions

Sleep Wake DisordersMental DisordersSleep Initiation and Maintenance Disorders

Interventions

Waiting ListsTherapeutics

Condition Hierarchy (Ancestors)

Nervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSleep Disorders, IntrinsicDyssomnias

Intervention Hierarchy (Ancestors)

Appointments and SchedulesOrganization and AdministrationHealth Services Administration

Study Officials

  • Ane Wilhelmsen-Langeland, PhD

    Haukeland University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ane Wilhelmsen-Langeland, PhD

CONTACT

Berge Osnes, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
All eligible participants will be informed that there may be a waitlist (length not specified) and receive a start-date without being informed that thay are in a waitlist group or not a waitlist group.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 6, 2020

First Posted

July 9, 2020

Study Start

December 17, 2021

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2027

Last Updated

June 18, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will share

The investigators plan to share the following individual participant data (IPD); Study protocol and Informed Consent Form (ICF) IPD Sharing Time Frame Definition: A description of when the IPD and any additional supporting information will become available and for how long, including the start and end dates or period of availability. This may be provided as an absolute date (for example, starting in January 2025) or as a date relative to the time when summary data are published or otherwise made available (for example, starting 6 months after publication). Limit: 1000 characters. IPD Sharing Access Criteria Definition: Describe by what access criteria IPD and any additional supporting information will be shared, including with whom, for what types of analyses, and by what mechanism. Information about who will review requests and criteria for reviewing requests may also be provided.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
By August 31st 2025
Access Criteria
Not yet decided. PI will be reviewing requests.

Locations